Serina Therapeutics, Inc. Operating Lease, Liability in USD from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Serina Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q2 2019 to Q3 2025.
  • Serina Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2025 was $311K, a 38.9% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)

Serina Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $311K -$198K -38.9% Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $362K -$200K -35.6% Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $412K -$208K -33.5% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $460K -$215K -31.9% Dec 31, 2024 10-Q 2025-11-13
Q3 2024 $509K Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $562K Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $620K Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $675K Dec 31, 2023 10-K 2025-03-24
Q3 2020 $109K -$420K -79.4% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $218K -$410K -65.3% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $325K Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $428K Dec 31, 2019 10-K/A 2020-03-31
Q3 2019 $529K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $628K Jun 30, 2019 10-Q 2020-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.